These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 18656504

  • 1. VEGF and ALS.
    Sathasivam S.
    Neurosci Res; 2008 Oct; 62(2):71-7. PubMed ID: 18656504
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical studies of vascular endothelial growth factor in skin of patients with amyotrophic lateral sclerosis.
    Suzuki M, Watanabe T, Mikami H, Nomura M, Yamazaki T, Irie T, Ishikawa H, Yasui K, Ono S.
    J Neurol Sci; 2009 Oct 15; 285(1-2):125-9. PubMed ID: 19592043
    [Abstract] [Full Text] [Related]

  • 3. Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis.
    Iłzecka J.
    Clin Neurol Neurosurg; 2004 Sep 15; 106(4):289-93. PubMed ID: 15297002
    [Abstract] [Full Text] [Related]

  • 4. VEGF: necessary to prevent motoneuron degeneration, sufficient to treat ALS?
    Lambrechts D, Storkebaum E, Carmeliet P.
    Trends Mol Med; 2004 Jun 15; 10(6):275-82. PubMed ID: 15177192
    [Abstract] [Full Text] [Related]

  • 5. Does VEGF represent a potential treatment for amyotrophic lateral sclerosis?
    Iłzecka J.
    Curr Opin Investig Drugs; 2006 Jan 15; 7(1):54-9. PubMed ID: 16425672
    [Abstract] [Full Text] [Related]

  • 6. The role of AMPA receptors and VEGF in ALS.
    Van Damme P.
    Verh K Acad Geneeskd Belg; 2009 Jan 15; 71(4):241-50. PubMed ID: 20084835
    [Abstract] [Full Text] [Related]

  • 7. VEGF reduces astrogliosis and preserves neuromuscular junctions in ALS transgenic mice.
    Zheng C, Sköld MK, Li J, Nennesmo I, Fadeel B, Henter JI.
    Biochem Biophys Res Commun; 2007 Nov 30; 363(4):989-93. PubMed ID: 17923114
    [Abstract] [Full Text] [Related]

  • 8. Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases.
    Bogaert E, Van Damme P, Van Den Bosch L, Robberecht W.
    Muscle Nerve; 2006 Oct 30; 34(4):391-405. PubMed ID: 16856151
    [Abstract] [Full Text] [Related]

  • 9. Another angiogenic gene linked to amyotrophic lateral sclerosis.
    Lambrechts D, Lafuste P, Carmeliet P, Conway EM.
    Trends Mol Med; 2006 Aug 30; 12(8):345-7. PubMed ID: 16843725
    [Abstract] [Full Text] [Related]

  • 10. [Skin changes in amyotrophic lateral sclerosis].
    Ono S.
    Brain Nerve; 2007 Oct 30; 59(10):1099-107. PubMed ID: 17969350
    [Abstract] [Full Text] [Related]

  • 11. Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the -2578AA genotype.
    Lambrechts D, Poesen K, Fernández-Santiago R, Al-Chalabi A, Del Bo R, Van Vught PW, Khan S, Marklund SL, Brockington A, van Marion I, Anneser J, Shaw C, Ludolph AC, Leigh NP, Comi GP, Gasser T, Shaw PJ, Morrison KE, Andersen PM, Van den Berg LH, Thijs V, Siddique T, Robberecht W, Carmeliet P.
    J Med Genet; 2009 Dec 30; 46(12):840-6. PubMed ID: 18413368
    [Abstract] [Full Text] [Related]

  • 12. Lack of association of VEGF promoter polymorphisms with sporadic ALS.
    Chen W, Saeed M, Mao H, Siddique N, Dellefave L, Hung WY, Deng HX, Sufit RL, Heller SL, Haines JL, Pericak-Vance M, Siddique T.
    Neurology; 2006 Aug 08; 67(3):508-10. PubMed ID: 16894118
    [Abstract] [Full Text] [Related]

  • 13. Exposure to cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients alters Nav1.6 and Kv1.6 channel expression in rat spinal motor neurons.
    Gunasekaran R, Narayani RS, Vijayalakshmi K, Alladi PA, Shobha K, Nalini A, Sathyaprabha TN, Raju TR.
    Brain Res; 2009 Feb 19; 1255():170-9. PubMed ID: 19109933
    [Abstract] [Full Text] [Related]

  • 14. Axon guidance proteins: novel therapeutic targets for ALS?
    Schmidt ER, Pasterkamp RJ, van den Berg LH.
    Prog Neurobiol; 2009 Aug 19; 88(4):286-301. PubMed ID: 19523502
    [Abstract] [Full Text] [Related]

  • 15. Can vitamin D delay the progression of ALS?
    Karam C, Scelsa SN.
    Med Hypotheses; 2011 May 19; 76(5):643-5. PubMed ID: 21310542
    [Abstract] [Full Text] [Related]

  • 16. Edited GluR2, a gatekeeper for motor neurone survival?
    Buckingham SD, Kwak S, Jones AK, Blackshaw SE, Sattelle DB.
    Bioessays; 2008 Nov 19; 30(11-12):1185-92. PubMed ID: 18937367
    [Abstract] [Full Text] [Related]

  • 17. Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis.
    Brockington A, Wharton SB, Fernando M, Gelsthorpe CH, Baxter L, Ince PG, Lewis CE, Shaw PJ.
    J Neuropathol Exp Neurol; 2006 Jan 19; 65(1):26-36. PubMed ID: 16410746
    [Abstract] [Full Text] [Related]

  • 18. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.
    Scaldaferri F, Vetrano S, Sans M, Arena V, Straface G, Stigliano E, Repici A, Sturm A, Malesci A, Panes J, Yla-Herttuala S, Fiocchi C, Danese S.
    Gastroenterology; 2009 Feb 19; 136(2):585-95.e5. PubMed ID: 19013462
    [Abstract] [Full Text] [Related]

  • 19. Human umbilical cord blood cells transfected with VEGF and L(1)CAM do not differentiate into neurons but transform into vascular endothelial cells and secrete neuro-trophic factors to support neuro-genesis-a novel approach in stem cell therapy.
    Rizvanov AA, Kiyasov AP, Gaziziov IM, Yilmaz TS, Kaligin MS, Andreeva DI, Shafigullina AK, Guseva DS, Kiselev SL, Matin K, Palotás A, Islamov RR.
    Neurochem Int; 2008 Dec 19; 53(6-8):389-94. PubMed ID: 18948156
    [Abstract] [Full Text] [Related]

  • 20. VEGF and Neuronal Survival.
    Calvo PM, Hernández RG, Pastor AM, de la Cruz RR.
    Neuroscientist; 2024 Feb 19; 30(1):71-86. PubMed ID: 36121037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.